Asthma Treatment With Add-On Dupilumab Plus Medium-Dose Inhaled Corticosteroid (ICS) Improved Lung Function and Asthma Control Compared With Placebo Plus High-Dose ICS

被引：0
|
作者：
Busse, William [1 ]
Castro, Mario [2 ]
Lugogo, Njira [3 ]
O'Byrne, Paul [4 ]
Bacharier, Leonard [5 ]
Xia, Changming [6 ]
Hardin, Megan [7 ]
Soliman, Mena [6 ]
Sacks, Harry [6 ]
Jacob-Nara, Juby [8 ]
Rowe, Paul [8 ]
Deniz, Yamo [6 ]
机构：
[1] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI USA
[2] Univ Kansas, Sch Med, Kansas City, KS USA
[3] Univ Michigan, Div Pulm & Crit Care Med, Ann Arbor, MI USA
[4] McMaster Univ, Hamilton, ON, Canada
[5] Vanderbilt Univ, Monroe Carell Jr Childrens Hosp, Med Ctr, Nashville, TN USA
[6] Regeneron Pharmaceut Inc, Tarrytown, NY USA
[7] Sanofi, Cambridge, MA USA
[8] Sanofi, Bridgewater, NJ USA
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2024年 / 153卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
L23
引用
收藏
页码：AB368 / AB368
页数：1
相关论文
共 50 条
  • [41] LATE-BREAKING ABSTRACT: A dose-ranging study of dupilumab in patients (pts) with uncontrolled asthma despite use of inhaled corticosteroids plus a long-acting beta-agonist (ICS/LABA): Final data
    Wenzel, Sally
    Castro, Mario
    Zhang, Bingzhi
    Pirozzi, Gianluca
    Sutherland, E. Rand
    Graham, Neil
    Evans, Robert R.
    Louis-Tisserand, Mariana
    Teper, Ariel
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [42] Early intervention with high-dose inhaled corticosteroids for control of acute asthma exacerbations at home and improved outcomes: A randomized controlled trial
    Yousef, Ejaz
    Hossain, Jobayer
    Mannan, Susan
    Skorpinski, Edward
    McGeady, Stephen
    ALLERGY AND ASTHMA PROCEEDINGS, 2012, 33 (06) : 508 - 513
  • [43] Once-Daily Tiotropium Respimat® Add-on to at Least Ics Maintenance Therapy Demonstrates Improved Lung Function in Patients with Symptomatic Asthma, Independent of Serum IgE or Blood Eosinophil Levels
    Tashkin, Donald P.
    Dahl, Ronald
    Virchow, Johann Christian
    Engel, Michael
    Moroni-Zentgraf, Petra
    Zaremba-Pechmann, Liliana
    Kerstjens, Huib A. M.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2016, 137 (02) : AB213 - AB213
  • [44] Late Breaking Abstract- Depemokimab efficacy/safety in patients with asthma on medium/high-dose ICS: The Phase IIIA randomised SWIFT-1/2 studies
    Jackson, David J.
    Wechsler, Michael E.
    Jackson, Daniel J.
    Korn, Stephanie
    Bernstein, David
    Pfeffer, Paul E.
    Martinez, Gustavo De Luiz
    Chen, Ruchong
    Saito, Junpei
    Jacques, Loretta
    Bird, Nicholas
    Schalkwijk, Stein
    Smith, Douglas
    Pavord, Ian D.
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [45] Dupilumab reduces risk of severe exacerbations and improves FEV1 in patients on both high- and medium dose ICS with uncontrolled, moderate-to-severe asthma from the phase 3 LIBERTY ASTHMA QUEST Study
    Pavord, I
    Papi, A.
    Wenzel, S.
    Park, H.
    Zhang, B.
    Staudinger, H.
    Maroni, J.
    Rowe, P.
    Amin, N.
    Pirozzi, G.
    Ruddy, M.
    Akinlade, B.
    Graham, N. M. H.
    Teper, A.
    ALLERGY, 2018, 73 : 463 - 464
  • [46] Efficacy of mometasone/indacaterol/glycopyrronium (MF/IND/GLY) on lung function and exacerbations in patients with inadequately controlled asthma with medium-dose ICS/LABA therapy (on GINA step 4) prior to study entry: Results from IRIDIUM study
    Kerstjens, Huib A. M.
    Maspero, Jorge F.
    Chapman, Kenneth R.
    Van Zyl-Smit, Richard
    Tanase, Ana-Maria
    Lawrence, David
    Pethe, Abhijit
    Mezzi, Karen
    D'Andrea, Peter
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [47] Fluticasone propionate/salmeterol combination provides more effective asthma control than low-dose inhaled corticosteroid plus montelukast (vol 106, pg 1088, 2000)
    Nelson, HS
    Busse, WW
    Kerwin, E
    Church, N
    Emmett, A
    Rickard, K
    Knobil, K
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2001, 107 (04) : 614 - 614
  • [48] Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial
    Wenzel, Sally
    Castro, Mario
    Corren, Jonathan
    Maspero, Jorge
    Wang, Lin
    Zhang, Bingzhi
    Pirozzi, Gianluca
    Sutherland, E. Rand
    Evans, Robert R.
    Joish, Vijay N.
    Eckert, Laurent
    Graham, Neil M. H.
    Stahl, Neil
    Yancopoulos, George D.
    Louis-Tisserand, Mariana
    Teper, Ariel
    LANCET, 2016, 388 (10039): : 31 - 44
  • [49] ETOPOSIDE COMBINED WITH CYCLOPHOSPHAMIDE PLUS VINCRISTINE COMPARED WITH DOXORUBICIN PLUS CYCLOPHOSPHAMIDE PLUS VINCRISTINE AND WITH HIGH-DOSE CYCLOPHOSPHAMIDE PLUS VINCRISTINE IN THE TREATMENT OF SMALL-CELL CARCINOMA OF THE LUNG - A RANDOMIZED TRIAL OF THE BRISTOL LUNG-CANCER STUDY-GROUPS
    HONG, WK
    NICAISE, C
    LAWSON, R
    MAROUN, JA
    COMIS, R
    SPEER, J
    LUEDKE, D
    HURTUBISE, M
    LANZOTTI, V
    GOODLOW, J
    ROZENCWEIG, M
    JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (04) : 450 - 456
  • [50] Effect of high dose inhaled beclomethasone for respiratory syncytial virus bronchiolitis during infancy on lung function and asthma at age 6-A randomised placebo-controlled trial
    Zomer-Kooijker, Kim
    van der Ent, Kors
    Ermers, Marieke
    Rovers, Maroeska
    Bont, Louis
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
12345